Chevy Chase Trust
CRL icon

Chevy Chase Trust’s Charles River Laboratories CRL Stock Holding History

Chevy Chase Trust’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.27M Sell
23,257
-988
-4% -$176K 0.01% 509
2026
Q1 		$4.18M Sell
24,245
-707
-3% -$131K 0.01% 520
2025
Q4 		$4.98M Sell
24,952
-164
-0.7% -$29.7K 0.01% 517
2025
Q3 		$3.93M Sell
25,116
-827
-3% -$131K 0.01% 532
2025
Q2 		$3.94M Sell
25,943
-875
-3% -$117K 0.01% 533
2025
Q1 		$4.04M Sell
26,818
-16
-0.1% -$2.68K 0.01% 534
2024
Q4 		$4.95M Sell
26,834
-849
-3% -$164K 0.02% 510
2024
Q3 		$5.45M Sell
27,683
-447
-2% -$92.9K 0.02% 499
2024
Q2 		$5.81M Sell
28,130
-283
-1% -$64.1K 0.02% 479
2024
Q1 		$7.7M Sell
28,413
-242
-0.8% -$57.8K 0.03% 452
2023
Q4 		$6.77M Sell
28,655
-166
-0.6% -$32.6K 0.02% 463
2023
Q3 		$5.65M Sell
28,821
-624
-2% -$128K 0.02% 471
2023
Q2 		$6.19M Sell
29,445
-122
-0.4% -$24.3K 0.02% 472
2023
Q1 		$5.97M Buy
29,567
+303
+1% +$68.7K 0.02% 477
2022
Q4 		$6.38M Sell
29,264
-1,795
-6% -$392K 0.03% 462
2022
Q3 		$6.11M Buy
31,059
+377
+1% +$81.4K 0.03% 460
2022
Q2 		$6.57M Buy
30,682
+342
+1% +$83.6K 0.03% 463
2022
Q1 		$8.62M Buy
30,340
+43
+0.1% +$13.3K 0.03% 449
2021
Q4 		$11.4M Sell
30,297
-659
-2% -$256K 0.04% 392
2021
Q3 		$12.8M Sell
30,956
-1,078
-3% -$448K 0.04% 357
2021
Q2 		$11.8M Buy
+32,034
New +$10.7M 0.04% 385
2020
Q1 		– Sell
-593
Closed -$91K – 708
2019
Q4 		$91K Buy
+593
New +$82.1K ﹤0.01% 735

Other funds holding CRL

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return

Chevy Chase Trust's CRL Position: Q2 2026 in Review

Chevy Chase Trust reduced its Charles River Laboratories (CRL) stake by 4.1% in Q2 2026, selling an estimated $176K and leaving 23,257 shares worth $5.27M. The position accounts for 0.01% of the portfolio, ranked #509.

Chevy Chase Trust first reported a position in CRL in Q4 2019 and has held it in 22 quarters since. The position peaked at $12.8M in Q3 2021. 569 funds tracked by Wall St. Rank hold CRL as of Q2 2026.

  • Chevy Chase Trust held 23,257 shares of Charles River Laboratories worth $5.27M as of Q2 2026.
  • Chevy Chase Trust sold 988 Charles River Laboratories shares in Q2 2026, an estimated $176K.
  • Charles River Laboratories made up 0.01% of Chevy Chase Trust's portfolio in Q2 2026, its #509 holding.
  • Chevy Chase Trust first reported a position in Charles River Laboratories in Q4 2019 and has held it in 22 quarters since.
  • Chevy Chase Trust's Charles River Laboratories position peaked at $12.8M in Q3 2021.
  • 569 funds tracked by Wall St. Rank held Charles River Laboratories as of Q2 2026.

Based on Chevy Chase Trust's 13F filing for Q2 2026, filed 14 Aug 2026.